Login
About UsDan    September 5, 2010
What We Do Minimize
 

BioGenerator works closely with university technology transfer offices, researchers, entrepreneurs, community leaders, and the investment community to identify promising plant and life science technologies with sufficient potential to form a start-up company.  BioGenerator provides guidance and advice to the university faculty or entrepreneurs about the commercialization process, and working with the entrepreneur/inventor, helps to formulate the business plan.  BioGenerator will also provide capital (seed funding) averaging between $50,000- $250,000 over an 18 month funding period to support start-up and commercial proof-of-concept activities.  In some instances, BioGenerator will also provide management support during the initial company formation, as well as assistance in attracting side-by-side or follow-on funding. 

 
 
BioGenerator Minimize
 

4041 Forest Park Avenue
St. Louis, MO 63108
314-615-6355
startup@biogenerator.org

 
 
Dan Broderick Minimize
 

 

Mr. Broderick has over 22 years of experience in the life sciences and venture capital industry. Prior to joining Prolog Ventures in 2007, Mr. Broderick spent 7 years with Mason Wells Biomedical Fund as a Managing Director where he was responsible for all aspects of investment activities. While at Mason Wells, Mr. Broderick served as a member of the Board of Directors of several portfolio companies including Gala Biotech, Mezzia, OpGen, Deltanoid Pharmaceuticals and ZyStor Therapeutics.
 
Prior to Mason Wells, Mr. Broderick spent 18 years at Mayo Clinic in Rochester, Minnesota, where for 12 years he served as Director of the Office of Technology Commercialization.  He has personally evaluated the commercial potential of hundreds of technologies in virtually every medical specialty. He has been directly responsible for negotiating and consummating over 100 medical technology commercialization agreements. He has experience with technology evaluation, market assessment, negotiations, academic institution technology transfer, and intellectual property management.
 
Mr. Broderick played a key role in the launch of Mayo Clinic’s $25 million venture investing program. He co-founded and served on the Board of Directors of IntraTherapuetics, Inc., CNSoftware and Medintell, Inc. In 1994, Mr. Broderick was honored with an appointment to the Staff of Mayo Clinic. 
 
Mr. Broderick is actively involved in the venture capital community on a regional and national level. He served on the Board of Directors of the National Venture Capital Association (NVCA). He has testified before the U.S. Congress on behalf of the NVCA; works on a number of NVCA committees, and Chaired the Research Committee. Mr. Broderick is the founder of the Mid-America Healthcare Investor Network (MHIN) and currently serves as President of the organization. He also is the past President of the Wisconsin Biotechnology and Medical Device Association, sat on the Advisory Boards of the University of Minnesota’s Office of Business Development and BioGenerator in St. Louis, Missouri,. He also served as a member of the Board of Trustees for the Medical College of Wisconsin Research Foundation and the University of Wisconsin – Milwaukee Research Foundation.
 
Mr. Broderick received a Bachelors Degree in Biology from Iowa State University in 1982. He has completed some graduate course work in Finance, Accounting and Marketing at Winona State University.
 
Mr. Broderick is 49 years old, and married with three children. He enjoys fishing, woodworking and renaissance art.
 
 
Memberships Minimize
 
 
 

BioGenerator

Minimize

 4041 Forest Park Avenue, Suite 120  St. Louis, MO 63108  (314) 615-6355  (314) 615-6351 (fax)

 
 Website Built and Maintained by Tuxedo Park Management, LLC 2009   Terms Of Use  Privacy Statement